Join to View Full Profile
7200 Cambridge StFl 10Houston, TX 77030
Phone+1 713-798-1750
Fax+1 713-798-4693
Dr. Nangia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2004 - 2007
University of Missouri Kansas City School of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2010 - 2026
LA State Medical License 2022 - 2023
IL State Medical License 2007 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients Start of enrollment: 2004 Sep 01
- Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01
- Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- Multilevel barriers and supportive care preferences of metastatic breast cancer patients and their caregivers: a mixed-methods analysis.Ashley Buchanan, Julie Nangia, Hoda Badr
Supportive Care in Cancer. 2025-02-11 - 1 citationsA mixed-methods study to inform development of a caregiver-specific problem list for cancer distress screening.Ashley Buchanan, Astrid Sarfo, Maria Lizette Rangel, Julie Nangia, Hoda Badr
Psycho-Oncology. 2023-10-01 - 4 citationsA Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, Robert Davis, Tao Wang
Clinical Cancer Research. 2023-08-15
Press Mentions
Know Your Threat for Breast Most CancersOctober 31st, 2022- Debunking Myths About CancerJune 10th, 2022
- Olivia Newton-John, 73, Rereleases Vinyl Edition of 1981 Hit Album, ‘Physical:’ Star Is Thriving While Surviving Stage 4 CancerMay 27th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
